Zobrazeno 1 - 10
of 13
pro vyhledávání: '"G. M. BOXER"'
Autor:
R B, Pedley, S A, Hill, G M, Boxer, A A, Flynn, R, Boden, R, Watson, J, Dearling, D J, Chaplin, R H, Begent
Publikováno v:
Cancer research. 61(12)
Solid tumors have a heterogeneous pathophysiology, which has a major impact on therapy. Using SW1222 colorectal xenografts grown in nude mice, we have shown that antibody-targeted radioimmunotherapy (RIT) effectively treated the well-perfused tumor r
Publikováno v:
Cancer research. 61(9)
Vascular endothelial growth factor (VEGF) is produced by cancer cells in response to hypoxia and is the primary stimulant of vascularization in solid tumors. Endothelial cells lining the blood vessels of these tumors have a high concentration of rece
Autor:
A, Mayer, E, Tsiompanou, D, O'Malley, G M, Boxer, J, Bhatia, A A, Flynn, K A, Chester, B R, Davidson, A A, Lewis, M C, Winslet, A P, Dhillon, A J, Hilson, R H, Begent
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 6(5)
In radioimmunoguided surgery (RIGS), a radiolabeled antibody is given i.v. before surgery and a hand-held gamma-detecting probe is used to locate tumor in the operative field. The rapid blood clearance and good tumor penetration of single-chain Fv an
Autor:
J, Bhatia, S K, Sharma, K A, Chester, R B, Pedley, R W, Boden, D A, Read, G M, Boxer, N P, Michael, R H, Begent
Publikováno v:
International journal of cancer. 85(4)
Antibody-directed enzyme prodrug therapy (ADEPT) targets an enzyme selectively to a tumor where it converts a relatively non-toxic prodrug to a potent cytotoxic drug. Previous clinical work using antibody-enzyme chemical conjugates has been limited b
Autor:
R B, Pedley, S K, Sharma, G M, Boxer, R, Boden, S M, Stribbling, L, Davies, C J, Springer, R H, Begent
Publikováno v:
Cancer research. 59(16)
The irregular nature of solid tumor vasculature produces a heterogeneous distribution of antibody-targeted therapies within the tumor mass, which frequently results in reduced therapeutic efficacy. We have, therefore, combined two complementary thera
Publikováno v:
Cancer research. 56(14)
Radioimmunotherapy (RIT) does not readily eradicate common solid tumors and therefore requires augmentation by complementary therapies that do not increase normal tissue damage. We have examined the efficacy of RIT combined with 5,6-dimethylxanthenon
Autor:
R A, Fisher, E S, Newlands, A J, Jeffreys, G M, Boxer, R H, Begent, G J, Rustin, K D, Bagshawe
Publikováno v:
Cancer. 69(3)
In three patients in whom a diagnosis of gestational trophoblastic tumor was possible on the basis of pathology and elevated levels of serum human chorionic gonadotrophin, locus-specific minisatellite probes were used to identify restriction fragment
Publikováno v:
Diseases of the colon and rectum. 34(3)
Radioimmunoguided surgery (RIGS) using an anti-CEA (A5B7) monoclonal antibody has been assessed in 52 patients (43 primary excisions and nine second look procedures) undergoing surgery for colorectal carcinoma. The antibody localized in 97.8 percent
Publikováno v:
Lancet (London, England). 335(8697)
11 patients registered with an initial diagnosis of partial hydatidiform mole (PHM) subsequently required chemotherapy for a gestational trophoblastic tumour. In a retrospective review by histopathological examination and measurement of DNA ploidy, t
Publikováno v:
British Journal of Cancer
A method of epitope analysis is described in which the binding of one monoclonal antibody (MAb) to radiolabeled carcinoembryonic antigen (CEA) competes with the subsequent binding of an immobilised second MAb. From the degree of blocking obtained, we